Robot-Assisted Training Versus Standard Training in Ischemic Stroke
Launched by ODENSE UNIVERSITY HOSPITAL · Feb 15, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of robot-assisted training compared to standard training for individuals who have experienced an ischemic stroke, which is a type of stroke caused by a blockage in blood flow to the brain. The goal is to see if using robotic technology can help improve movement, physical abilities, fatigue levels, and overall quality of life for people who have moderate to severe challenges in these areas, particularly those who are several months post-stroke.
To participate, individuals should be between 65 and 74 years old and have had a stroke that occurred at least 6 months ago but less than 18 months ago. They should have been through some rehabilitation and have moderate to severe impairments in their ability to move or walk. Participants will be randomly placed in either the robot-assisted training or standard training group and will work on exercises designed to help improve their condition. It's important to note that individuals with certain health conditions, like severe fatigue or cognitive challenges, may not be eligible for this trial. This study is currently recruiting participants, and those interested should discuss it with their doctor to see if they qualify.
Gender
ALL
Eligibility criteria
- Inclusion:
- • 1. Ischemic apoplexia.
- • 2. Chronic state (6-24 months post-stroke).
- • 3. Subacute rehabilitation terminated (subacute phase defined as until 6 months post-stroke).
- 4. Moderately-severely impaired:
- • 1. Modified Rankin Scale Score 3-5.
- • 2. Scandinavian Stroke Scale Leg Motor Function Score 0-4 and/or SSS gait function 0-9.
- • 5. Approved by referring doctor
- Exclusion:
- • 1. Prior SAH
- • 2. Infarct located in the cerebellum or brain stem
- • 3. Severe fatigue making study completion improbable.
- • 4. Cognitive deficits impeding study participation.
- • 5. Inability to walk independently pre-stroke.
- • 6. Recurrence of cardiovascular/cerebrovascular accidents.
- • 7. Pre-existing neurological diseases or ongoing cancer treatment.
- • 8. Refusing group allocation.
- • 9. Concurrent participation in another clinical trial potentially interacting with the present trial.
About Odense University Hospital
Odense University Hospital is a leading academic medical center located in Denmark, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital is committed to enhancing patient outcomes and fostering collaboration among multidisciplinary teams. With a focus on translating scientific discoveries into practical applications, Odense University Hospital leverages its state-of-the-art facilities and expertise to conduct rigorous trials across various medical fields, ensuring adherence to the highest ethical and regulatory standards. Through these efforts, the hospital aims to contribute significantly to the global body of medical knowledge and improve the quality of care for patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odense, , Denmark
Copenhagen, , Denmark
Patients applied
Trial Officials
Jon Skovgaard Jensen, Ph.d.-student
Principal Investigator
Department of Clinical Research, University of Southern Denmark
Anders Holsgaard-Larsen, Professor
Study Director
Odense University Hospital and Department of Clinical Research, University of Southern Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported